Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-26T18:26:38.468Z Has data issue: false hasContentIssue false
  • English
  • Français

Successful Control of Hepatitis B Surface Antigenemia in a Dialysis Unit Without Geographic or Machine Isolation

Published online by Cambridge University Press:  02 January 2015

Victor S. Ostrower ,
Meyer D. Lifschitz ,
Philip C. Craven  and
Dwight M. Williams
Victor S. Ostrower
Affiliation:
Gastroenterology Section, Hemodialysis Section, and Infectious Diseases Section, Audie L. Murphy Memorial Veterans Hospital, and the Department of Medicine, University of Texas Health Science Center, San Antonio, Texas
Meyer D. Lifschitz*
Affiliation:
Gastroenterology Section, Hemodialysis Section, and Infectious Diseases Section, Audie L. Murphy Memorial Veterans Hospital, and the Department of Medicine, University of Texas Health Science Center, San Antonio, Texas
Philip C. Craven
Affiliation:
Gastroenterology Section, Hemodialysis Section, and Infectious Diseases Section, Audie L. Murphy Memorial Veterans Hospital, and the Department of Medicine, University of Texas Health Science Center, San Antonio, Texas
Dwight M. Williams
Affiliation:
Gastroenterology Section, Hemodialysis Section, and Infectious Diseases Section, Audie L. Murphy Memorial Veterans Hospital, and the Department of Medicine, University of Texas Health Science Center, San Antonio, Texas
*
University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284
Get access Rights & Permissions [Opens in a new window]

Abstract

Persistent hepatitis B infections among patients and frequent new hepatitis B infections among both patients and staff were a major problem in our dialysis unit during its first two and one-half years of operation. During this time the mean quarterly rate of conversion to HBsAg positivity among patients ranged from 0-60% (mean 12%); in staff it ranged from 0-13%. Control efforts, including strict temporal isolation, improved sanitary measures, and use of parallel plate dialyzers without geographic or machine isolation, were begun late in 1976. After a four-month lag, new HBsAg conversions ceased among the 30 patients and staff at risk, despite continued dialysis of eight HBsAg-positive patients (at least four of whom were HBeAg-positive). Over the succeeding three years the conversion rate was zero in both patients and staff. This experience suggests that conservative control measures without geographic separation of patients may be sufficient to control an established outbreak of hemodi-alysis-related hepatitis B. Controlled prospective trials of this hypothesis are warranted.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 2 , Issue 2 , 03/04 1981 , pp. 101 - 104
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1981

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Eastwood, JB, Curtis, JR, Wing, AJ, de Wardener, HE. Hepatitis in a maintenance hemodialysis unit. Ann Intern Med 1968; 69:59–66.CrossRefGoogle Scholar
2.London, WT, DiFiglia, M, Sutnick, AI, Blumberg, BS. An epidemic of hepatitis in a chronic-hemodialysis unit. N Engl J Med, 1969; 281:571–78.CrossRefGoogle Scholar
3.Snydman, DR, Bryan, JA, Macon, EJ, Gregg, MB. Hemodialysis-associated hepatitis. Report of an epidemic with further evidence on mechanisms of transmission. Am J Epidemiol 1976; 104:563–70.CrossRefGoogle ScholarPubMed
4.Snydman, DR, Bryan, JA, Dixon, RE. Prevention of nosocomial viral hepatitis, type B (hepatitis B). Ann Intern Med 1975; 83:838–45.CrossRefGoogle ScholarPubMed
5.Center for Disease Control. Hepatitis—Control measures of hepatitis B in dialysis centers. Viral Hepatitis Investigations and Control Series, Nov 1977.Google Scholar
6.Snedecor, GW, Cochran, WG. Statistical Methods, 6th Ed. Ames, Iowa, Iowa State University Press, 1967.Google Scholar
7.Snydman, DR, Bregman, D, Bryan, JA. Hemodialysis-associated hepatitis in the United States, 1974. J Infect Dis 1977; 135:687–91.CrossRefGoogle Scholar
8.Polakoff, S. Public Health Laboratory Service Survey. Decrease in the incidence of hepatitis in dialysis units associated with prevention programme. Br Med J 1974; 4:751–54.Google Scholar
9.Polakoff, S. Problems of protection against virus B Hepatitis. Postgrad Med J 1976; 52:580–2.CrossRefGoogle ScholarPubMed
10.Snydman, DR, Bryan, JA, London, WT, Werner, B, Bregman, D, Blumberg, BSet al.Transmission of hepatitis B associated with hemodialysis: Role of malfunction (blood leaks) in dialysis machines. J Infect Dis 1976; 134:562–70.CrossRefGoogle ScholarPubMed
11.Favero, MS, Maynard, JE, Petersen, NJ, Boyer, DM, Bond, WW, Berquist, KRet al.Hepatitis-B antigen on environmental surfaces. (Letter.) 1973; Lancet 2:1455.Google Scholar
12.Danken, J, Uitentuis, J, Houwen, B, Tegzess, AM, van der Hem, GK. Hepatitis B surface antigen in environmental samples from hemodialysis units. J Infect Dis 1976; 134:123–27.Google Scholar
13.Alter, JH, Seef, LB, Kaplan, PM, McAuliffe, VJ, Wright, EC, Gerin, JLet al.Type B Hepatitis: The infectivity of blood positive for “e” antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med 1976; 295:909–13.CrossRefGoogle ScholarPubMed